BioXcel Therapeutics
BTAI
$1.18
Share price
-0.84%
Change (1 day)
-93.26%
Change (1 year)
Categories
P/S ratio for BioXcel Therapeutics (BTAI)
P/S ratio as of June 2024 (TTM): 25.2
According to BioXcel Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 25.22. At the end of 2023 the company had a P/S ratio of 62.6.
P/S ratio history for BioXcel Therapeutics from 2018 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 62.6 | -96.1% |
| 2022 | > 1000 | |
| 2021 | N/A | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |